APA (7th ed.) Citation

SH, B., JH, O., SJ, K., IR, Y., SH, K., GS, P., . . . SG, C. (2019). Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma. Nuclear medicine and molecular imaging, 53(4), 263. https://doi.org/10.1007/s13139-019-00602-0

Chicago Style (17th ed.) Citation

SH, Boo, O. JH, Kwon SJ, Yoo IR, Kim SH, Park GS, Choi BO, Jung SE, and Cho SG. "Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma." Nuclear Medicine and Molecular Imaging 53, no. 4 (2019): 263. https://doi.org/10.1007/s13139-019-00602-0.

MLA (9th ed.) Citation

SH, Boo, et al. "Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma." Nuclear Medicine and Molecular Imaging, vol. 53, no. 4, 2019, p. 263, https://doi.org/10.1007/s13139-019-00602-0.